title: Kinetic studies on drug disposition in rabbits. I. Renal excretion of iodopyracet and sulfamethizole.
abstract: In order to quantify the renal handling of iodopyracet (IOD) and sulfamethizole (SMZ), single-drug clearance studies in rabbits were performed under quasi-steady state conditions with stepwise increasing the infusion rate of IOD or SMZ. Although concentration dependence of plasma protein binding was observed for both drugs, the urinary excretion rate of IOD was proportional to its total plasma concentration at low total plasma concentrations of 0.05-0.8 mM. On the other hand, the relationship between urinary excretion rate and total plasma concentration of SMZ was a concave-ascending curve at low plasma concentrations and the renal clearance of SMZ was sensitive to changes in plasma protein binding. However, renal clearances referenced to unbound plasma concentration at total plasma concentrations of 0.05 mM for IOD and SMZ were 9.5 and 38 l/h, respectively. Those values were much greater than the effective plasma flow in rabbits. These facts indicated that the intrinsic clearances at the sites of tubular secretion were high and that the rates of secretion were fully or partially limited by the renal plasma flow. Furthermore it was suggested that unbound drug was liberated from plasma protein at the sites of tubular secretion. The data obtained at high plasma concentrations indicated that the tubular secretion of IOD had capacity limited characteristics and that the urinary excretion of SMZ involved tubular reabsorption as well as saturable tubular secretion. From the data obtained, a perfusion-limited pharmacokinetic model was constructed characterizing the excretory processes, namely, glomerular filtration, passive tubular reabsorption, saturable tubular secretion and reequilibrium between bound and unbound drugs in plasma. For both drugs, the estimates for bulk flow rate were reasonable values of effective renal plasma flow and the dissociation constants for tubular secretion agreed well with those for in vitro renal cortex accumulation, suggesting that the kinetic model based on physiological concepts was useful for the understanding of the drug elimination processes.
authors.affiliation: Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Katayama
authors.forename: H
authors.initials: H
authors.lastname: Ohtani
authors.forename: T
authors.initials: T
authors.lastname: Kawabe
authors.forename: H
authors.initials: H
authors.lastname: Mizuno
authors.forename: M
authors.initials: M
authors.lastname: Endoh
authors.forename: M
authors.initials: M
authors.lastname: Kakemi
authors.forename: T
authors.initials: T
authors.lastname: Koizumi
mesh_terms: D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D007468:Iodopyracet / Q000493:pharmacokinetics*; D007668:Kidney / Q000378:metabolism*; D007672:Kidney Cortex / Q000033:anatomy & histology; D007678:Kidney Glomerulus / Q000502:physiology; D007684:Kidney Tubules / Q000378:metabolism; D008954:Models, Biological; D010477:Perfusion; D011485:Protein Binding; D011817:Rabbits / Q000378:metabolism*; D013419:Sulfamethizole / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D013432:Sulfathiazoles / Q000493:pharmacokinetics*
chemical_list: D001798:Blood Proteins; D013432:Sulfathiazoles; D013419:Sulfamethizole; D007468:Iodopyracet